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Abstract
Artificial sweeteners are sugar substitutes that add sweetness to foods and beverages without the extra calories found
in sugar. These additives are used to help patients with diabetes avoid hyperglycemia and assist people in losing weight
or avoiding weight gain by providing a replacement to higher
calorie sugar-sweetened foods. Artificial sweeteners can be
found in many sugar-free beverages, candies and gum, as
well as pharmaceutical products. Although artificial sweeteners are often recommended over the sugar-sweetened alternatives in weight loss and diabetes prevention, the use of
such products are not without risk. Studies have been
conducted to assess artificial sweeteners involvement in contributing to cancer, genotoxicity and diabetes. To provide
optimal health care to patients, it is imperative to know the
implications involved with these risks. Pharmaceutical products formulated for oral and peroral administration have
been sweetened by both artificial and natural sweeteners,
and the utilization of artificial sweeteners has been deemed
more beneficial than its natural counterpart. As health care
professionals, it is our job to counsel patients on the benefits
of artificial sweeteners over natural sweeteners along with
the importance of using artificial sweeteners in moderation.

Introduction and Background Information on Artificial
Sweeteners
Currently there are five artificial sweeteners approved by the
U.S. Food and Drug Administration (FDA) including sucralose, aspartame, saccharin, stevia and acesulfame potassium (acesulfame). These compounds are regulated by the
FDA as food additives and were evaluated for safety before
being made available for public consumption (Table 1).1Artificial sweeteners are currently the gold standard as additives
in food and beverages consumed by those with type II diabetes mellitus and those who either want to lose weight or
avoid weight gain.2 Artificial sweeteners help diabetics avoid
hyperglycemia and maintain a more consistent blood sugar
level. Artificial sweeteners add little to no calories to achieve
the equivalent sucrose sweetness within their food and beverage formulations, which makes artificial sweeteners a viable choice for those limiting their daily caloric intake.1 By
limiting both sugar intake and overall calories consumed, the
risk of developing diabetes and obesity decreases.3
However, artificial sweetener consumption has been linked
to an increased cancer incidence, with both genotoxic and
carcinogenic properties in studies conducted in lab rats. Subsequently, when more stringent safety studies were performed, an increase in cancer incidence was not observed in
human subjects. However, long-term studies have not been
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conducted to assess the overall effect artificial sweeteners
have in humans after consumption over a lifetime.4
Toxicity Testing
A study done in 2002, at the Center of Advanced Study, Cell
and Chromosome Research, Department of Botany at the
University of Calcutta, in conjunction with the Department of
Internal Medicine at the University of Kentucky, studied the
genotoxicity of the artificial sweeteners aspartame, acesulfame and saccharin. Genotoxicity was evaluated according to
how much damage was sustained to the DNA when exposed
to external factors. The study population included mice that
were fed increasing dosages of one sweetener, and their
bone marrow tissue was analyzed for genotoxicity. From the
test performed in this study it was concluded that each of the
three sweeteners induced DNA damage in the mouse bone
marrow cell. This study concluded that it is impossible to
assess the long-term effects of artificial sweetener use, but
use should be limited based on the genotoxic effects found
within the study.6
A bioassay evaluation of aspartame carcinogenicity in Sprague-Dawley rats was conducted by the Cesare MaltoniCancer Research Center of the European Ramazzini Foundation. Aspartame was added to the rat's normal feed at the
concentrations of 100,000; 50,000; 10,000; 2,000; 400; 80
and from the control group 0 ppm. These concentrations
were calibrated to parallel the human consumption of 5,000;
2,500; 500; 100; 20; 4 or 0 mg/kg, respectively, each day.
Aspartame was added to the feed when the rats were 8
weeks old until natural death, upon which an extensive autopsy was conducted. Both the male and female population
showed a significant increase in the incidence of malignant
tumors with (p::; 0.05) for males and (p ::; 0.01) as compared
to controls. The study concluded that with aspartame consumption, the risk of malignant tumor development increased within the rat subjects. These findings show more
research is necessary to adequately assess aspartame carcinogenicity with long-term consumption in the human
population.7
Sucrose versus Artificial Sweeteners
A prospective cohort study examined the association of artificially and sugar-sweetened beverages in the development
of type II diabetes.a The study included 51,529 men ages 40
to 75 years who were recruited to form a Health Professionals Follow-Up Study. The study consisted of questionnaires
mailed every other year to assess health status and lifestyle
factors. After excluding the men who did not respond to the
survey and those with type II diabetes, cardiovascular disease and cancer, a 131-item semiquantitative food frequency
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Table 1. Overview of FDA Approved Artificial Sweeteners 1,2,3,s
Artificial
Sweetener

Brand
Name

Sweetness Compared
to Sugar

Physical
Characteristics

Food
Additive

Sucralose

Splenda

600x

Heat-Stable

Diet Foods, SugarFree Beverages, Gum,
Gelatin; can be used in
baking

Aspartame

Nutrasweet and Equal

220x

Combination of two
amino acids

Sugar-Free
Beverages

Saccharin

Sweet N'Low, Sweet
Twin, NectaSweet

300x

Stevia

Truvia, Sun Crystals,
Pure Via

200-300x

Dietary Supplement/
Extracted from Stevia
rebaudiana plant

Diet Foods and
Beverages

Acesulfame

Sunett, Sweet One

200x

Heat-Stable

Mostly in Carbonated
Beverages; Baking

questionnaire was sent out to 40,389 qualified men every
four years to assess the consumption of sugar-sweetened
and artificially sweetened beverages. Artificially sweetened
beverages included caffeinated, caffeine-free, and noncarbonated low-calorie colas. Sugar-sweetened beverages included caffeinated and caffeine-free colas; other carbonated
sugar-sweetened beverages, and noncarbonated sugarsweetened beverages (fruit punch, lemonade and other fruit
drinks). Groups were divided into those that consumed
sugar-sweetened beverages versus artificially sweetened
beverages and then further divided into frequency of consumption.
A total of 2,680 incident cases of type II diabetes were noted
over 20 years of follow-up.a Hazard ratios (HR) were determined using a Cox proportional hazard to determine the association of sugar-sweetened versus artificially sweetened
beverages to type II diabetes. Statistical adjustments were
made for smoking, physical activity, alcohol intake, multivitamin use, family history of diabetes, high triglycerides, high
blood pressure, diuretic use, previous weight change, lowcalorie diet and body mass index (BMI). After adjustments
were made, consumption of sugar-sweetened beverages was
associated significantly to the development of type II diabetes with an HR of 1.24, confidence interval (CJ) of (1.09 to
1.40) and a p-value <0.01. Consumption of artificially sweetened beverages did not show a significant association with
type II diabetes (HR 1.09 [CI 0.98-1.21]) and p-value of0.13,
after adjustments.

The major limitation to the study was weak external validity
(lack of generalizability) caused by the study population
being solely comprised of adult, white males.a Strengths included the measuring of beverage intake prior to type II dia-

Diet Foods and
Beverages

betes development, similar socioeconomic status of the participants, beverage intake calculated as cumulative averages,
a control present for several health and lifestyle factors and
the large sample size. By measuring intake prior to the development of type II diabetes and adjusting for other health and
lifestyle risk factors for type II diabetes, the study was able to
limit many confounding variables that would likely have
been a concern in determining the association of the two different sweeteners and type II diabetes. Although the study
did not find significant statistical evidence for the association
of artificial sweeteners to the development of type II diabetes, the study was limited to the effects of artificial sweeteners in adult, white males and cannot be properly generalized
to include the general population. Therefore, the results were
not conclusive in determining if artificial sweeteners have a
reduced risk of type II diabetes when compared to natural
sugars.
Pharmaceutical Application
Artificial sweeteners are extremely prevalent in the field of
pharmaceutics. There is an abundance of oral medications
that rely on this means of sweetening enhancement to produce a palatable dosage form for the patient. Dosage forms
that rely on these sweetening enhancers include tablets,
powders, solutions, suspensions, and medical products in
these dosage forms range from prescription to nonprescription medications as well as herbals and vitamins.9
Sweeteners such as sucrose have been used in the past to
overcome the bitterness and odor of a large amount of medications for patients. An example would be the commonly prescribed pain management medication morphine sulfate JR in
oral solution. 10 Due to the chronic nature of this medication;
sucrose in this solution can prove to be problematic. Two
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issues predominate with this usage: dental caries and hyperglycemia in diabetic patients. Despite these issues, patient
adherence to the medication still dictates the use of these
sweeteners. Recently, artificial sweeteners have been a preferred alternative to classic sweeteners to alleviate the dental erosion and large intake of sugars. Studies such as Koning
et al. and Nettleton et al. show conflicting data with the latter
claiming that artificial sweeteners are related to the diagnosis of type II diabetes.s. 11 With inconclusive data health care
providers, and specifically pharmacists, can play a large role
in counseling patients and selecting safer medications that
are artificially sweetened.
A population that is greatly influenced by sweeteners is pediatrics. In pharmacy, sweeteners are used extensively in regard to ease of administration of medication to children. Children are especially susceptible to dental caries and tooth
erosion from an excess of sweetener in their diet as well as
medications. As more pediatric medications come on the
market, sweeteners will become a more problematic issue.
Medications such as Chlor-Trimeton contain sucrose in the
syrup formulation while other drugs such as Children's Tylenol elixir contains both aspartame and mannitol: a sugar and
an artificial sweetener. Brief, short-term use has not proven
to cause such adverse effects; however, long-term use of
sucrose-sweetened medications has been associated with
dental caries, teeth erosion, and diabetes.12 Therefore, shortterm use is a way in which artificial sweeteners can provide
less adverse effects and be a better sweetener in pediatric
medications.
Pharmacists can provide education to patients on artificial
sweeteners through medication therapy management. Making the patient aware of sweetening agents, whether it is
sucrose or an artificial sweetener, can improve the patient's
conditions as well as his or her quality of life. It is important
as pharmacists to explain how neither natural nor artificial
sweeteners are healthy, yet artificial sweeteners are the
preferred choice of the two.1 This is especially imperative in
patients who have conditions such as high blood pressure,
obesity and diabetes.

Conclusion
Sweetening enhancers are heavily used throughout society
whether it is through diet or pharmaceutical products. With
diets high in sugars, prevalence of type II diabetes and obesity have reached record-breaking highs. Through extensive
research, we have evaluated and compared the effects of using sugar sweeteners such as sucrose versus FDA-approved
artificial sweeteners. Through the studies conducted, we can
conclude that the adverse effects of sugar sweeteners are
proven to be more detrimental than those of artificial sweeteners. Despite studies claiming that artificial sweeteners may
have negative health effects, the data is inconclusive and the
diagnoses of diabetes and obesity were attributed more toward sugar sweeteners than artificial sweeteners.
Pharmacists can play a major role in counseling recommendations in regard to sweetening medications for patients.
Sweetening is a necessary aspect of pharmaceuticals in order

to maintain patient adherence; therefore, the benefits of artificial sweeteners outweigh the risks. With artificial sweeteners, moderation is essential. Patients cannot avoid the intake
of these sweeteners in their medications; however, dietary
adjustments should be recommended to reduce the intake of
artificial sweeteners. By educating patients, pharmacists can
play a major role in helping patients to more safely consume
products with artificial sweeteners.
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